Scared to Start Mounjaro — and What to Do With That Feeling

If the needle is the thing that's stopping you

This is a question our prescribers hear most weeks, and the honest answer is that the vast majority of people who describe themselves as needle-phobic find the Mounjaro KwikPen far less dramatic than they expected. The needle itself is short and very fine, designed for subcutaneous fat tissue in the abdomen, thigh or upper arm, where there are far fewer nerve endings than in muscle. You press a button; you do not see the needle go in. The click confirms the dose has been delivered.

That said, needle anxiety is not trivial and it does not disappear by being told it should. A few things help practically: sitting down, choosing your preferred injection site in advance, taking a slow breath before you press the button, and doing the injection at a consistent time each week so it becomes routine rather than an event. If your anxiety is severe, tell your prescriber. They can talk through techniques, and in some cases discuss alternatives. The practical steps for your first injection are worth reading before your delivery arrives, not after.

Room temperature eases the injection slightly, taking the pen out of the fridge a few minutes beforehand is fine, though the exact window for how long is in the Patient Information Leaflet that comes with your pen.

Side effects: what is actually likely to happen

Fear of side effects often comes from reading every listed possibility at once. The reality is more manageable. The most common effects are gastrointestinal (nausea, constipation, loose stools, or indigestion) and they are most likely to occur in the first few days after starting or after a dose increase. For many people they are mild and pass within one to two weeks. The NHS guidance on tirzepatide covers the full side-effect profile clearly and is worth reading.

The 2.5mg starting dose exists specifically to reduce the likelihood of a harsh introduction. If you want to understand what the early weeks involve before committing, the guide to starting tirzepatide walks through what to expect from dose one onwards. Eating smaller portions, staying well hydrated, and avoiding very fatty meals during the first weeks all reduce GI discomfort. If side effects feel unmanageable, your prescriber can slow the titration schedule, that is an option, not a failure.

There are symptoms that do need urgent medical attention: severe stomach pain that radiates to the back may indicate pancreatitis, which is a known but uncommon side effect that the MHRA highlighted in a Drug Safety Update in January 2026. Knowing which symptoms to take seriously (and which are ordinary adjustment) is genuinely useful, not alarming.

The worry that it might not work for you specifically

Clinical trials give population averages, not personal guarantees. In SURMOUNT-1, participants using tirzepatide at the highest dose lost an average of around 20% of body weight over 72 weeks, across thousands of adults. Some lost more, some less. The honest position is that no one can tell you in advance exactly where you will land, and anyone who promises a specific outcome is overstepping. What the evidence does show clearly is that tirzepatide produces clinically meaningful weight loss in the majority of people who use it alongside a reduced-calorie diet and increased activity, as reviewed by NICE in TA1026.

If weight loss after six months at the highest tolerated dose is less than 5%, NICE guidance recommends reviewing whether to continue. That review point is built into responsible clinical practice, not a cliff edge. The prescription model means your progress is checked, not left to chance. If something is not working, there is a conversation to be had, not a silent subscription rolling on.

Cost is sometimes part of the hesitation too. Private treatment involves a real financial commitment, and understanding what a Mounjaro prescription actually costs (including what is and is not included in different providers' prices) is a sensible step before you start. For context on what the treatment journey looks like in full, the weight-loss treatment overview sets it out plainly.

Taking the step from thinking about it to actually deciding

The decision to start is a clinical one, made with a prescriber who has looked at your health picture, not a commitment you make alone in a search engine at midnight. If you are broadly eligible (adult, BMI of 30 or above, or 27 or above with a relevant weight-related condition) and you have been considering this for a while, the consultation is where the real conversation starts. You are not signing up for anything by asking the questions.

Being nervous before starting is not a signal that something is wrong. It is a reasonable response to trying something new that has a real effect on your body. What helps most people is moving from vague worry to specific information, which is exactly what a prescriber review is for. If you would like to understand the timing of when to begin, guidance on timing your first dose covers practical considerations like upcoming travel or life events. And if you want to understand the broader picture before booking anything, how nume works as a service is a fair place to start. When you are ready, speaking to our prescribers is the next step.